Background The most common major complication after pancreatic resection is the
postoperative pancreatic fistula (POPF). Somatostatin analogs can reduce POPF, but the …

Background The use of synthetic analogues of somatostatin following pancreatic surgery is
controversial. The aim of this meta-analysis is to determine whether prophylactic …

Background Leakage from the pancreatic stump is a leading cause of morbidity following
pancreatic surgery. It is essential to evaluate the effect of somatostatin analogues (SAs) …

Background The role of somatostatin and its analogues in reducing complications after
pancreatic resection is controversial. This is a meta-analysis of the evidence of benefit …

Background Pancreatic resections are associated with high morbidity (30% to 60%) and
mortality (5%). Synthetic analogues of somatostatin are advocated by some surgeons to …

Objective: The aim of this study was to evaluate the efficacy of somatostatin and its
analogues in prevention of postoperative complications after pancreaticoduodenectomy …

Objective Postoperative pancreatic fistula/POPF is the most feared complication in
pancreatic surgery. Although several systematic reviews investigated the impact of …

Background: The use of somatostatin analogues (SAs) following pancreaticoduodenectomy
(PD) is controversial. Method: Literature databases were searched systematically for …

Background The benefit of somatostatin for the prevention of pancreatic fistula has been
debated widely in the literature. The aim of this study was to evaluate the efficacy of …

Background Somatostatin analogues (SA) are currently used to prevent postoperative
pancreatic fistula (POPF) development. However, its use is controversial. This study …